COPD: Another Lucrative Big Pharma Fail

'Medical costs for chronic obstructive pulmonary disease (COPD) in the United States are more than $32 billion each year, according to new research from the U.S. Centers for Disease Control and Prevention.

The yearly financial toll of COPD is expected to reach an estimated $49 billion by 2020.'


No comments: